Cell Density Influences Expression Of Pluripotency Genes And Differentiation In Colorectal Cancer Cells | 9369
Journal of Computer Science & Systems Biology
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Recent understanding of colorectal tumours (along with other tumour cell types) indicates that they contain a small population
of cancer stem cells (CSC) that are capable of self-renewal and generation of all the differentiated cell types in the tumour.
Another feature of colorectal tumours is that the cells appear to undergo a transition at the invasive front, that endows the tumour
cells with the ability to invade and metastasize. This process resembles the epithelial- mesenchymal transition (EMT). A possible
link between these two processes, has recently been identified when it was shown that normal mammary epithelial cells that
were induced to undergo an EMT, acquired stem cell characteristics. An
system that mimics the changes occurring in
colorectal cancer cells during EMT would be significant in identifying factors involved in these changes. The colon cancer cell
line, SW480, when grown to low or high cell density resembles cell populations at the invasive front (mesenchymal-like) and
central mass (epithelial-like) of the tumour, respectively. We show that
, is differentially expressed in SW480 cells, being
present in low density cells. We also show that
expression is regulated by the Wnt-signaling effector, beta-catenin in a
density dependent manner.
/ Nanog expressing cells are also positive for colorectal cancer (CRC) stem cell (SC) marker.
We propose a mechanism whereby expression of beta-catenin in low cell density cells induces the expression of
, preventing differentiation. These
expressing cells may be the cancer stem cells as determined by CRC-SC
Debalina Sarkar has completed her Ph.D. in cancer studies from University of Wales, Bangor. Her postdoctoral work is on hemophilia from University
of Florida and on endocrine cancer from Harvard Medical School. She has published first author papers in journals like ?International Journal of
Cancer? and have published editorials. She has served as the review committee for American Society of Gene & Cell Therapy annual meeting 2012.
He also serves as the editorial board member for the journal Genetic vaccines and
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals